ABSCH Q&A Webinar - Monitoring utilization through the ABS Clearing-House
30 March 2023 - 09:00 EST
Nominations for the Informal Advisory Committee to the Access and Benefit-sharing Clearing-House to the Nagoya Protocol
Deadline for nominations: 31 March 2023
Notification: Nominations for the 5th meeting of the IAC on Capacity-building for the Implementation of the Nagoya Protocol
Deadline for nominations: 15 March 2023
Parties au Nagoya Protocol
Lancer le processus
To discover and understand novel proteins isolated from various marine microorganisms.
CBD National Focal Point | Cartagena Protocol National Focal Point | BCH National Focal Point | Emergency Measures (Article 17) Contact Point | ABS National Focal Point | Clearing-House Mechanism National Focal Point | SBSTTA National Focal Point
CBD National Focal Point | ABS National Focal Point | Clearing-House Mechanism National Focal Point | SBSTTA National Focal Point | Programme of Work on Protected Areas National Focal Point
Fichiers de référence
Contents 1. CABI’s ABS Policy and Best Practices 1 1.1 How CABI uses genetic material 1 1.2 Benefits CABI provides from its use of genetic material 2 2. Swiss legislation in relation to Access and Benefit Sharing (ABS) 2 3. CABI’s Best Practices and implementation in Switzerland 2 3.1 Accessing genetic resources for use (in situ) 3 3.2 Receiving biological and genetic resources from collaborators, collections or other providers (ex situ) 5 3.3 Transferring genetic material and/or resources outside of CABI 5 3.4 Enforcement and compliance 5 Annex 1: A glossary of useful terms and their definitions 6 Annex 2. Decision tree outlining the general steps of the CABI best practice. 8 Annex 3. CABI genetic resources database with an example entry 9 Annex 4. CABI generic MTA for supply of genetic resources 10
New updated edition of this comprehensive global survey of national ABS regulations, highlights the continuous progress in the establishment and implementation of national ABS regulations around the world.
This document has been produced in order to provide assurance to Nagoya Protocol member states, regulators, researchers, collaborators and peers, that the Wellcome Sanger Institute has initiated and carries out appropriate processes and procedures to enable compliance with global Access and Benefit Sharing (hereafter; ABS) measures and compliance with the UK ABS legislation5 implementing the Nagoya Protocol1 for scientific research undertaken. Within this document are the tools, processes and procedures, comprising Institute policy, that when employed correctly staff and associates of the Wellcome Sanger Institute can be confident that they are conducting their research in accordance with the UK ABS legislation and in turn, ABS legislation in force globally.
The Bio-Cultural Community Protocol of the Ogiek peoples provides an insight into important social and cultural values of our people. It highlights and documents our traditional knowledge, way of life, customary laws and the key elements of Free Prior Informed Consent (FPIC) when engaging with external actors such as government, research Institutions, pharmaceutical companies and other private investors.